Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure.

Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure. Abstract Text:

Shu Kasama,Takuji Toyama,Hiroyuki Sumino,Naoya Matsumoto,Yuichi Sato,Hisao Kumakura,Yoshiaki Takayama,Shuichi Ichikawa,Tadashi Suzuki,Masahiko Kurabayashi,Shu Kasama,Takuji Toyama,Hiroyuki Sumino,Naoya Matsumoto,Yuichi Sato,Hisao Kumakura,Yoshiaki Takayama,Shuichi Ichikawa,Tadashi Suzuki,Masahiko Kurabayashi,

The activation of the renin-angiotensin-aldosterone system prevents the uptake of norepinephrine in the myocardium. However, the additive effects of combined spironolactone and candesartan on cardiac sympathetic nerve activity (CSNA) have not been determined. We investigated the effects of the angiotensin-receptor blocker candesartan alone and in combination with spironolactone on CSNA in patients with congestive heart failure (CHF). METHODS: Fifty patients with CHF (left ventricular ejection fraction [LVEF] < 45%) were randomly assigned to candesartan plus spironolactone (group A; n = 25) or to candesartan alone (group B; n = 25). All patients were also treated with a loop diuretic. The delayed percent denervation, delayed heart-to-mediastinum count (H/M) ratio, and washout rate (WR) were determined from (123)I-metaiodobenzylguanidine (MIBG) scintigraphy, and plasma brain natriuretic peptide (BNP) concentration was measured before and 6 mo after treatment. The LV end-diastolic volume (LVEDV), LV end-systolic volume (LVESV), and LVEF were also determined by echocardiography. RESULTS: After 6 mo, all of these parameters were improved in both groups. However, the degree of change in the percent denervation was -14 +/- 12 in group A and -7 +/- 10 in group B (P < 0.05); the change in the H/M ratio was 0.19 +/- 0.18 in group A and 0.08 +/- 0.14 in group B (P < 0.05), the change in WR was -12% +/- 8% in group A and -5% +/- 13% in group B (P < 0.05), and the change in plasma BNP was -100 +/- 83 pg/mL in group A and -43 +/- 97 pg/mL in group B (P < 0.05). The degree of change in LVEDV, LVESV, and LVEF in group A tended to be better than that in group B, but these changes were not statistically significant. Moreover, there were significant correlations between changes in the (123)I-MIBG scintigraphic findings and changes in the LVEDV (% denervation, r = 0.692, P < 0.001; H/M ratio, r = -0.437, P < 0.05; and WR, r = 0.505, P < 0.01) or the LVESV (% denervation, r = 0.663, P < 0.001; H/M ratio, r = -0.438, P < 0.05; and WR, r = 0.532, P < 0.01) in group A. In contrast, there was no relationship between these parameters in group B. CONCLUSION: These findings indicate that the combination of spironolactone and candesartan may be more beneficial for CSNA and LV performance than candesartan alone in patients with CHF.

Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure. Publishing Authors By Initials

S Kasama,T Toyama,H Sumino,N Matsumoto,Y Sato,H Kumakura,Y Takayama,S Ichikawa,T Suzuki,M Kurabayashi,S Kasama,T Toyama,H Sumino,N Matsumoto,Y Sato,H Kumakura,Y Takayama,S Ichikawa,T Suzuki,M Kurabayashi,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of nuclear medicine : official publication

VOLUME: 48

Page Numbers: 1993-2000

Journal Abbreviation: J. Nucl. Med.

ISSN: 0161-5505

DAY: 15

MONTH: 11

YEAR: 2007

Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 217410

Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure.

AFFILIATION: Department of Cardiovascular Medicine, Gunma University School of Medicine, Maebashi, Japan. s-kasama@bay.wind.ne.jp

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Nucl Med

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure Related Publications

• A potential pitfall of MR imaging for assessing mandibular invasion of squamous cell carcinoma in the oral cavity.
• Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure.
• An investigation of magnetic resonance imaging features in 14 patients with synovial chondromatosis of the temporomandibular joint.
• Changes in horizontal jaw position and intraoral pressure.
• Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction.
• Effects of aging, menopause, and hormone replacement therapy on forearm skin elasticity in women.
• Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.
• Imaging of epithelial cancer in sub-terahertz electromagnetic wave.
• Insulin Resistance in Patients with Stroke is Related to Visceral Fat Obesity and Adipocytokines.
• Lentiviral Vector-mediated SERCA2 Gene Transfer Protects Against Heart Failure and Left Ventricular Remodeling After Myocardial Infarction in Rats.
• Long-term nicorandil therapy improves cardiac sympathetic nerve activity after reperfusion therapy in patients with first acute myocardial infarction.
• MRI and clinical findings of posterior disk displacement in the temporomandibular joint.
• MRI findings of temporomandibular joints with disk perforation.
• Mechanisms and clinical implications of asymptomatic mitral regurgitation in patients with left ventricular dysfunction.
• Network structure for control of coupled multiple nonlinear oscillators.
• Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure.
• Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
• Prostaglandin F(2alpha) Inhibits SERCA2 Gene Transcription Through an Induction of Egr-1 in Cultured Neonatal Rat Cardiac Myocytes.
• Relationship between Carotid Atherosclerosis and Lumbar Spine Bone Mineral Density in Postmenopausal Women.
• Relationship between brachial arterial endothelial function and lumbar spine bone mineral density in postmenopausal women.
• Relationship between metabolic syndrome and sleep-disordered breathing in patients with cardiovascular disease--metabolic syndrome as a strong factor of nocturnal desaturation.
• Runx2 represses myocardin-mediated differentiation and facilitates osteogenic conversion of vascular smooth muscle cells.
• [A case of HLA-DR8 positive sarcoidosis following polymyositis and Sjögren's syndrome]
• [A case of Wegener's granulomatosis associated with the syndrome of inappropriate secretion of ADH]
• [A case of allergic bronchopulmonary aspergillosis that itraconazole showed a definite effect temporarily]
• [A case of anaphylactoid purpura associated with nephrosis followed by pulmonary tuberculosis]
• [A case of small cell lung carcinoma complicated by Lambert-Eaton myasthenic syndrome]
• [New evidence of conjugated estrogen and 17beta-estradiol]
• [Oxidative stress and mild hypertension]